Supernus Pharmaceuticals | SUPN - Market Capitalization


Supernus Pharmaceuticals reported $2.22B in Market Capitalization this September of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Abbott USD 158.05B 20.36B Jun/2026
ANI Pharmaceuticals USD 1.88B 133M Jun/2026
Aurora Cannabis CAD 193.82M 133.39M Mar/2026
Bristol-Myers Squibb USD 117.66B 6.17B Jun/2026
Canopy Growth CAD 557.13M 99.33M Mar/2026
Cara Therapeutics USD 30M 336M Mar/2026
Corcept Therapeutics USD 9.33B 5.02B Jun/2026
Eisai JPY 1.2T 219.32B Jun/2026
Eli Lilly USD 1.13T 260.54B Jun/2026
Novo Nordisk A/S DKK 1.4T 373.76B Jun/2026
Pacira USD 998M 83M Jun/2026
Pfizer USD 138.44B 15.37B Jun/2026
Supernus Pharmaceuticals USD 2.7B 277M Jun/2026
United Therapeutics USD 23B 2.19B Jun/2026
Xeris Pharmaceuticals USD 1000M 303M Mar/2026